At meeting held on 11 February 2025
The Board of Lupin at its meeting held on 11 February 2025 has approved the transfer of the over-the-counter (OTC) Consumer Healthcare business of the company, on a slump sale basis, to a wholly owned subsidiary that is proposed to be incorporated.The Board also approved the incorporation of a wholly owned subsidiary in the name and style LUPINLIFE Consumer Healthcare or any other appropriate name, as may be approved by the Ministry of Corporate Affairs.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
